Results 81 to 90 of about 483,333 (340)

Prognostic significance of concentric left ventricular hypertrophy at peritoneal dialysis initiation

open access: yesBMC Nephrology, 2021
Background Concentric left ventricular hypertrophy (cLVH) is a common left ventricular geometric pattern in patients undergoing maintenance dialysis, including peritoneal dialysis (PD).
Misato Tomura   +8 more
doaj   +1 more source

Patients' experiences of transitioning between different renal replacement therapy modalities : a qualitative study [PDF]

open access: yes, 2020
BACKGROUND: Different kidney replacement therapy modalities are available to manage end-stage kidney disease, such as home-based dialysis, in-center hemodialysis, and kidney transplantation.
Combes, G   +7 more
core   +1 more source

Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2019
BACKGROUND AND OBJECTIVES Higher fruit and vegetable intake is associated with lower cardiovascular and all-cause mortality in the general population.
V. Saglimbene   +31 more
semanticscholar   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai   +2 more
wiley   +1 more source

Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2019
BACKGROUND AND OBJECTIVES Current hemodialysis techniques fail to efficiently remove the protein-bound uremic toxins p-cresyl sulfate and indoxyl sulfate due to their high degree of albumin binding.
M. Madero   +9 more
semanticscholar   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki   +11 more
wiley   +1 more source

Establishing a core outcome set for peritoneal dialysis : report of the SONG-PD (standardized outcomes in nephrology-peritoneal dialysis) consensus workshop [PDF]

open access: yes, 2020
Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse, are measured inconsistently, and may not be important to patients, families, and clinicians.
Abraham, Georgi   +118 more
core   +2 more sources

Patient Perspectives on the Meaning and Impact of Fatigue in Hemodialysis: A Systematic Review and Thematic Analysis of Qualitative Studies.

open access: yesAmerican Journal of Kidney Diseases, 2019
RATIONALE & OBJECTIVE Fatigue is a highly prevalent and debilitating symptom in patients on hemodialysis therapy due to the uremic milieu, the hemodialysis treatment itself, and other comorbid conditions.
J. Jacobson   +15 more
semanticscholar   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion [PDF]

open access: yes, 1974
A 38-year-old white female, hepatitis B antigen negative, developed fluminating hepatic failure associated with oliguria and severe azotemia after two halothane anesthesia and without exposure to other hepatotoxic drugs or blood transfusions.
A. G. Redeker   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy